FDA Inspection 1166197 — Community Blood Center of the Ozarks
The FDA completed an inspection of Community Blood Center of the Ozarks on March 10, 2022 in Springdale, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 10, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Springdale, AR (United States)